Albemarle: Argus Research cuts target price to $135 from $230
ALB•Argus Research cut its target price for Albemarle to $135 from $230.
Related News
Exelixis target price raised to $54 from $52
EXEL•
Vaxcyte edges lower after $1 billion raise to fund pneumococcal vaccine
PCVX•
Pacira Biosciences: Truist Securities raises target price to $31 from $30
PCRX•
Beam Global to acquire Norwegian drone company ScoutDI for $24 million in cash and stock
BEEM•
London court quashes five more UK rate-rigging convictions
BCS•